{{header
 | author     = 
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2013
 | month      = 07
 | day        = 18
 | notes      = ''{{USBill|113|S.|1322}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 1
 | title      = Synthetic Abuse and Labeling of Toxic Substances Act of 2013 ( S. 1322; 113th Congress)
 | bill       = 1322
 | billtype   = s
 | purpose    = To amend the Controlled Substances Act relating to controlled substance analogues.
 | wikipedia  =
}}

{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|S. 1322}}


{{Center|IN THE SENATE OF THE UNITED STATES}}


{{Center|July 18, 2013}}


{{Center|
shitburger[[w:|Ms. Klobuchar]] (for herself,
shitburger[[w:|Mr. Graham]] , and
shitburger[[w:|Mrs. Feinstein]] ) introduced the following bill; which was read twice and referred to the [[w:United States Senate Committee on the Judiciary|Committee on the Judiciary]] }}


{{Center|A BILL}}

To amend the Controlled Substances Act relating to controlled substance analogues.

=Section 1. Short title=

This Act may be cited as the “Synthetic Abuse and Labeling of Toxic Substances Act of 2013” or the “SALTS Act” .

=Sec. 2. Controlled substance analogues=

 Section 203 of the Controlled Substances Act( [http://www.law.cornell.edu/uscode/text/21/813 21 U.S.C. 813] )is amended—
:(1) by striking “A controlled” and inserting “(a)In general.—A controlled” ; and
:(2) by adding at the end the following:

<blockquote>

===(b) Determination– ===

In determining whether a controlled substance analogue was intended for human consumption under subsection (a), the following factors may be considered, along with any other relevant factors:
:(1) The marketing, advertising, and labeling of the substance.
:(2) The known efficacy or usefulness of the substance for the marketed, advertised or labeled purpose.
:(3) The difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold.
:(4) The diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance.
:(5) Whether the defendant knew or should have known the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.

===(c) Limitation– ===

For purposes of this section, evidence that a substance was not marketed, advertised, or labeled for human consumption, by itself, shall not be sufficient to establish that the substance was not intended for human consumption..
</blockquote>

{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
